Clinical Trial Update: Double-Masked Trial of NOVA22007 (1mg/mL Ciclosporin/Cyclosporine) Versus Vehicle in Pediatric Patients With Active Severe Vernal Keratoconjunctivitis [Phase 3]

View source ↗

Summary

Phase 3 double-masked trial of NOVA22007 (cyclosporine) vs vehicle in pediatric active severe Vernal Keratoconjunctivitis completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vernal Keratoconjunctivitis

Drugs mentioned

• NOVA22007 (cyclosporin)

Snippet

Sponsor: Santen SAS | Conditions: Vernal Keratoconjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2022-03-28